License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals make the process as quick and easy as possible.

Use the Technology Explorer below to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.

Deep Tech Download Newsletter

For the latest on active investment opportunities and developments at companies emerging from U of T Research, sign up for the Deep Tech Download newsletter. With more than $1.5 billion raised by research-based companies in the last 5 years, Deep Tech Download is your inside track to get involved!

Technology Explorer

Technology Keywords
Recombinant Antibodies Network (RAN) Antibodies , Cancer , Advanced Health Technologies , Biotechnology , Pharmaceuticals , Therapeutics 
NUAK Inhibitors as Therapeutics for Cancer and Fibrosis Advanced Health Technologies , Biotechnology , Cancer , Cell Signaling , Drug Discovery , Health & Related Life Sciences , Inflammation , Pharmaceuticals , Small Molecules , Therapeutics , Oncology , Fibrosis 
Inhibition of PKN1 As Therapy For Chronic Lymphocytic Leukemia (CLL) Advanced Health Technologies , Biotechnology , Cancer , Drug Discovery , Health & Related Life Sciences , Leukemia , Pharmaceuticals , Small Molecules , Therapeutics 
Excimer-Based Molecular Tool for Detection of Proximally Phosphorylated Protein Sites Cancer , Detection Methods , Fluorescent sensors , Proteins , Sensors & Instrumentation 
Mammalian Membrane Two-Hybrid (MaMTH) Technology: a Novel Protein Interaction and Drug Discovery Tool Cancer , Cell Signaling , Disease Detection , Drug Discovery , Genetics , Membrane Proteins , Neurological Disorders , Protein-Protein Interactions , Proteins 
Measurement of Rodent Interaction with a Cage Lid Cancer , Neurological Disorders , Sensors & Instrumentation , Sensory Systems & Rehabilitation 
MNAzyme-Based Gold Nanoparticle Sensor Cancer , Diagnostics , Disease Detection , Medical Devices , Nanomaterials and Nanoparticles , Patient Care , Point-of-Care , Sensors & Instrumentation 
Multiplexed Genetic Detection with Isothermal Signal Amplification Cancer , Chips , Diagnostics , Disease Detection , Genetics , Infectious Diseases , Nanomaterials and Nanoparticles , Point-of-Care , Polymers , Quantum Dots , Smartphones 
Nanoparticle-based Thermal Contrast Agents Cancer , Diagnostics , Disease Detection , Infectious Diseases , Nanomaterials and Nanoparticles 
UBA5 Inhibitors for the Treatment of Cancer and Leishmaniasis Cancer , Disease Detection , Drug Discovery , Leukemia , Multiple Myeloma 

VPRI Role

  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515